Aissel Technologies Launches konectar AI (kAI), An Agentic AI Purpose-Built for Life Sciences

STONEHAM, Mass. - July 22, 2026 - PRLog -- Aissel Technologies, a leading provider of enterprise KOL intelligence solutions for the life sciences industry, today announced the launch of konectar AI (kAI), an agentic AI assistant built to transform how life sciences teams access, interpret, and act on KOL intelligence.

kAI is embedded natively within konectar, Aissel's flagship KOL management platform. It serves as a conversational intelligence layer that enables Medical Affairs, Commercial, Clinical, Strategy, and MSL teams to move from fragmented research to real-time, decision-ready insights, no dashboards, filters, or technical training required.

Grounded Intelligence, Not Generic AI

Unlike generic AI tools that rely on static, pre-trained datasets, kAI is built on Context Engineering, a retrieval-based architecture that dynamically synthesizes data from konectar's continuously updated, curated, and validated KOL database before generating a response.

This approach delivers 95%+ data accuracy, full traceability to source, and significantly lower hallucination risk compared to generic AI tools. Every answer kAI produces is grounded in verified, structured data, making it suitable for the high-stakes decision-making environments life sciences teams operate in.

Commenting on the launch, Prasad Patil, Co-founder and CEO of Aissel Technologies, said:

"Life sciences decisions demand more than just data, they require context, accuracy, and speed. With kAI, we are bringing together the power of generative AI and deeply validated KOL intelligence to help teams move from fragmented research to confident, real-time decision-making. Our vision has always been to deliver meaningful value through technology, and kAI is a significant step forward in that journey."

From Weeks of Research to Minutes

Life sciences organizations have long relied on fragmented workflows, spending weeks compiling KOL profiles, mapping influence networks, and synthesizing competitive intelligence across therapeutic areas and geographies.

kAI compresses this process by delivering structured, actionable intelligence across KOL identification, scientific and clinical trends, competitive landscapes, and congress planning. What previously required days of manual research can now be accomplished in minutes, with an 80% reduction in research time and 3x faster KOL identification.

Teams can ask questions in plain English and receive instant, insight-driven answers grounded in real data. Queries like "Who are the top KOLs in interventional cardiology by citation impact?" or "Build an engagement plan for our Medical Affairs team attending a cardiology congress" return structured, ready-to-act outputs.

Availability

konectar AI (kAI) is now available to existing clients and new enterprise customers across North America, Europe, and Asia-Pacific. To request a personalized demo, contact sales@aissel.com  or visit www.aissel.com.